本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ascendis Pharma A/S

218.10
-3.3900-1.53%
盘后218.100.00000.00%18:52 EST
成交量:168.44万
成交额:3.67亿
市值:134.56亿
市盈率:-48.06
高:222.99
开:211.00
低:211.00
收:221.49
52周最高:242.00
52周最低:118.03
股本:6,169.52万
流通股本:6,008.34万
量比:1.78
换手率:2.80%
股息:- -
股息率:- -
每股收益(TTM):-4.5384
每股收益(LYR):-6.7615
净资产收益率:-818.43%
总资产收益率:-7.69%
市净率:-65.15
市盈率(LYR):-32.26

数据加载中...

2026/02/11

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2026/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities